De novo design of membranolytic anticancer peptides by adaptive machine learning

Open access
Autor(in)
Datum
2018Typ
- Doctoral Thesis
ETH Bibliographie
yes
Altmetrics
Persistenter Link
https://doi.org/10.3929/ethz-b-000304225Publikationsstatus
publishedExterne Links
Printexemplar via ETH-Bibliothek suchen
Verlag
ETH ZurichThema
Machine learning; Cancer; Drug design; Artificial intelligence; Anticancer agentOrganisationseinheit
03852 - Schneider, Gisbert / Schneider, Gisbert
ETH Bibliographie
yes
Altmetrics